News
Important Only
Regional risk pools receive joint grant from Global Shield Solutions Platform
By Henry GaleApril 15 - (The Insurer) - The Global Shield Solutions Platform has agreed to provide a grant worth 4.7 million euros ($5.3 million) to the four regional catastrophe risk pools to fund shared initiatives, Africa's risk pool said in a LinkedIn post on Tuesday.The funding will be used...Reuters
Tue, Apr 15
Arundo Re targets Indian subcontinent build-out with Chirimar hire
By Ryan HewlettApril 15 - (The Insurer) - Paris-based reinsurer Arundo Re, the recently rebranded CCR Re, has named Kshitij Chirimar as senior underwriter for the Indian subcontinent, a move designed expand the carrier’s footprint across the region.Chirimar brings over a decade of experience in the ...Reuters
Tue, Apr 15
Win-Light Global Acquires An Additional 1,479,890 Connectm Shares, Boosting Buy-Out Group's Holdings To 24.5% Of Shares Outstanding
April 15 (Reuters) - ConnectM Technology Solutions Inc CNTM.O:WIN-LIGHT GLOBAL ACQUIRES AN ADDITIONAL 1,479,890 CONNECTM SHARES, BOOSTING BUY-OUT GROUP'S HOLDINGS TO 24.5% OF SHARES OUTSTANDINGCONNECTM TECHNOLOGY SOLUTIONS INC: BOARD OF DIRECTORS CONTINUES TO EVALUATE BUYOUT PROPOSALReuters
Tue, Apr 15
Immunitybio Announces FDA Submissions Of Supplemental BLA For Nmibc Papillary Disease And For Expanded Access Of Anktiva®To Treat Lymphopenia
April 15 (Reuters) - Immunitybio Inc IBRX.O:IMMUNITYBIO ANNOUNCES FDA SUBMISSIONS OF SUPPLEMENTAL BLA FOR NMIBC PAPILLARY DISEASE AND FOR EXPANDED ACCESS OF ANKTIVA® TO TREAT LYMPHOPENIAIMMUNITYBIO ANNOUNCES FDA SUBMISSIONS OF SUPPLEMENTAL BLA FOR NMIBC PAPILLARY DISEASE AND FOR EXPANDED ACCESS OF A...Reuters
Tue, Apr 15
Toragen- Positive Safety Data From Phase 1 Trial Of Tgn-S11, In Patients With Cancers Associated With Hpv
April 15 (Reuters) - TORAGEN- POSITIVE SAFETY DATA FROM PHASE 1 TRIAL OF TGN-S11, IN PATIENTS WITH CANCERS ASSOCIATED WITH HPVTORAGEN- EVIDENCE OF ACTIVITY IS IDENTIFIED FOR TGN-S11 AS A MONOTHERAPY AND IN COMBINATION WITH KEYTRUDATORAGEN- PHASE 1 TRIAL MET BOTH PRIMARY ENDPOINTS OF PROVING SAFETY A...Reuters
Tue, Apr 15
FDA Clears Ceribell’S Clarity Algorithm For Pediatric Patients
April 15 (Reuters) - CeriBell Inc CBLL.O:FDA CLEARS CERIBELL’S CLARITY™ ALGORITHM FOR PEDIATRIC PATIENTS, MAKING CERIBELL THE FIRST AND ONLY FDA-CLEARED AI TECHNOLOGY FOR DETECTION OF ELECTROGRAPHIC SEIZURES IN PATIENTS AGES 1 YEAR AND OLDERReuters
Tue, Apr 15
Citi aiming for Banamex IPO by year-end, says regulatory delay possible
April 15 (Reuters) - Citigroup C.N is aiming to be ready for an initial public offering of its Banamex unit by the end of the year, but securing regulatory approvals could push the timeline into 2026, its CFO Mark Mason said on Tuesday.Reuters
Tue, Apr 15
Alignment Healthcare Strengthens Leadership To Scale Its Ai-Enabled Medicare Advantage Platform With Two Key Appointments
April 15 (Reuters) - Alignment Healthcare Inc ALHC.O:ALIGNMENT HEALTHCARE STRENGTHENS LEADERSHIP TO SCALE ITS AI-ENABLED MEDICARE ADVANTAGE PLATFORM WITH TWO KEY APPOINTMENTSReuters
Tue, Apr 15
